WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now…
WOONSOCKET, R.I., 2016-May-25 — /EPR Retail News/ — CVS Health (NYSE: CVS) today announced it will expand access to the opioid overdose-reversal drug naloxone in seven additional states this summer, contributing to a total of 30 states where the life-saving medication will be more accessible to CVS Pharmacy patients. CVS Health's naloxone program establishes a standing…